<DOC>
	<DOCNO>NCT02968953</DOCNO>
	<brief_summary>This treatment plan intend use UX007 ( triheptanoin ) treatment single patient Glucose Transporter 1 ( GLUT1 ) Deficiency Syndrome .</brief_summary>
	<brief_title>Treatment With UX007 Single Patient With GLUT1 Deficiency Syndrome</brief_title>
	<detailed_description>This treatment plan intend use UX007 ( triheptanoin ) treatment single patient Glucose Transporter 1 ( GLUT1 ) Deficiency Syndrome . Patient already try acceptable treatment GLUT1 either side effect cause treatment discontinue ( Ketogenic Diet ) current treatment show efficacy difficult sustain long duration give patient 's age ( modified Atkins diet ) . Due patient 's ongoing neuroregression lack viable treatment , use UX007 ( triheptanoin ) warrant . There comparable satisfactory alternative therapy treat patient 's severely debilitating condition potential benefit patient justify potential risk treatment . The potential risk UX007 ( triheptanoin ) unreasonable give context patient 's condition .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<criteria>This treatment plan intend use UX007 ( triheptanoin ) treatment single patient Glucose Transporter 1 ( GLUT1 ) Deficiency Syndrome . Not applicable study include one patient .</criteria>
	<gender>Female</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>